JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

West Pharmaceutical Services Inc

Chiusa

SettoreSettore sanitario

304.94 -1.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

301.92

Massimo

305.01

Metriche Chiave

By Trading Economics

Entrata

-7.9M

132M

Vendite

700K

805M

P/E

Media del settore

41.003

60.328

EPS

2.04

Rendimento da dividendi

0.31

Margine di Profitto

16.41

Dipendenti

10,800

EBITDA

-7.6M

210M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+5.07% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.31%

2.24%

Utili prossimi

23 lug 2026

Prossima data del Dividendo

6 mag 2026

Prossima data del' Ex Dividendo

29 apr 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.1B

20B

Apertura precedente

306.35

Chiusura precedente

304.94

Notizie sul Sentiment di mercato

By Acuity

50%

50%

155 / 348 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 gen 2026, 11:40 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma

23 apr 2026, 16:47 UTC

Utili

This Pharma Stock Is Soaring After Earnings. It's a Sneaky GLP-1 Play. -- Barrons.com

12 gen 2026, 11:02 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie to Invest More Than $175 Million to Acquire, Modernize, Integrate Plant >ABBV WST

12 gen 2026, 11:01 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie Plans to Hire About 200 Employees at Acquired Site >ABBV WST

12 gen 2026, 11:01 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie To Buy Device Manufacturing Plant in Tempe, Ariz., Associated Intellectual Property From West >ABBV

12 gen 2026, 11:00 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in U.S. >ABBV WST

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

5.07% in crescita

Previsioni per 12 mesi

Media 321.67 USD  5.07%

Alto 400 USD

Basso 275 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

11 ratings

9

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

155 / 348 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat